The global opioid use disorder treatment market involves medications and therapies for individuals struggling with opioid addiction and dependence. Medications like buprenorphine and methadone bind to opioid receptors in the brain and body to relieve drug craving and block the effects of illicit opioids.

The global opioid use disorder treatment market is estimated to be valued at US$ 3728.51 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

One of the key drivers for the opioid use disorder treatment market growth is the increasing prevalence of opioid use disorder. According to the National Institute on Drug Abuse, around 2 million people in the United States suffered from prescription opioid use disorder in 2019. Easy access and increasing misuse of prescription opioids has fueled the growth of opioid addiction. Treatment medications like buprenorphine and methadone help address opioid dependence and curb drug misuse by satisfying opioid cravings.

Additionally, supportive government policies and regulations are also boosting the opioid use disorder treatment market. For instance, in October 2018, the SUPPORT act was passed which expanded access to MAT for opioid addiction. It also aims to strengthen prevention, treatment and recovery support services to deal with substance abuse disorders. Growing awareness about the benefits of medication-assisted treatment is compelling more individuals to opt for MAT solutions. These factors collectively are expected to drive the demand for opioid use disorder treatments over the forecast period.

SWOT Analysis
Strength: Opioid Use Disorder treatment involves three monthly injected formulations of buprenorphine which help reduce dependency and cravings significantly over a period of time. This long-acting treatment reduces the instances of relapses and removes the challenges of daily medication intake. The drugs also have minimal withdrawal symptoms thus improving treatment compliance.

Weakness: Oral naltrexone tablets used in treatment have poor compliance due to strong nausea, vomiting, and liver toxicity as side effects. The cost of monthly injected formulations is also quite high which may not be covered by all insurance firms restricting their widespread use.

Opportunity: Emerging economies in Asia Pacific have a vast untreated patient base for Opioid Use Disorder indicating high future sales potential. Several new drug delivery methods like monthly injections, implants are being researched which can further boost treatment rates.

Threats: Regulations on prescription and distribution of opioids are very strict in different nations posing supply chain and logistical challenges. The social stigma around drug abuse patients can also negatively impact their decision to seek and continue medical care. Strong lobbying from pain management groups limits stringent control over prescription opioids circulation.

Key Takeaways

The global Opioid Use Disorder Market Growth is expected to witness high growth. The global opioid use disorder treatment market is estimated to be valued at US$ 3728.51 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024-2031.

Regional analysis indicates North America dominates currently due to an early start of disease awareness campaigns, prescribed treatments and supportive regulations for patients’ rights in the region. However, the Asia Pacific region is witnessing fastest gains on account of improving access to healthcare facilities as well as rising substance abuse cases reported especially among young urban populations.

Key players operating in the Opioid Use Disorder market are Mylan NV, Indivior Plc, Hikma Pharmaceuticals PLC, Teva Pharmaceuticals, Neurocrine Biosciences Inc and Orexo AB.

The key players are focusing on expanding their product range and geographical presence to leverage future opportunities. Partnerships with regional healthcare providers and advocacy groups are helping boost awareness and availability amid the rising affected populations. Innovation in new formulations offering enhanced efficacy and compliance can strengthen their market shares in the coming years.

For more details on the report,   Read- https://whotimes.com/change-harmony-exploring-the-dynamic-world-of-ion-exchange-membranes-for-applications/

 For more insights, read- https://www.pressreleasebulletin.com/opioid-use-disorder-market-trends-size-and-share-analysis/